Pharmacological and Electrophysiological Characterization of Novel NMDA Receptor Antagonists

scientific article published on 01 June 2018

Pharmacological and Electrophysiological Characterization of Novel NMDA Receptor Antagonists is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/ACSCHEMNEURO.8B00154
P932PMC publication ID6249113
P698PubMed publication ID29767953

P50authorFrancesc X. SuredaQ42172321
Esther Gratacòs-BatlleQ59553089
Santiago VazquezQ61159610
Rosana LeivaQ119833275
P2093author name stringJon W Johnson
David Soto
Andreea L Turcu
Lara León-García
Matthew B Phillips
P2860cites workParadigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyondQ22251042
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insultsQ24558984
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysisQ26861399
Molecular bases of NMDA receptor subtype-dependent propertiesQ27012689
Crystal structure of a heterotetrameric NMDA receptor ion channelQ27684006
NMDA receptor structures reveal subunit arrangement and pore architectureQ27684638
Activation of NMDA receptors and the mechanism of inhibition by ifenprodilQ27704785
The glutamate receptor ion channelsQ28137916
The chemical biology of clinically tolerated NMDA receptor antagonistsQ28248958
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugsQ28270170
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonistsQ28287381
Glutamate receptor ion channels: structure, regulation, and functionQ28290774
Mechanism of NMDA Receptor Inhibition and ActivationQ30774134
Azapropellanes with anti-influenza a virus activity.Q33889072
NMDA receptor subunits: diversity, development and diseaseQ33950711
Glutamate as a neurotransmitter in the healthy brainQ34048502
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disordersQ34138025
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?Q34212543
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.Q34407523
Extrasynaptic NMDA receptor involvement in central nervous system disordersQ34415681
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and functionQ34629359
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and diseaseQ34651972
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterizationQ34668783
Pathologically activated therapeutics for neuroprotectionQ34691239
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.Q34756031
Recent insights into the mode of action of memantine and ketamineQ35054539
Structure and function of glutamate receptor ion channelsQ35672501
Glutamate in CNS disorders as a target for drug development: an updateQ35992523
Synaptic NMDA receptors mediate hypoxic excitotoxic deathQ35993627
Mechanism of action of memantineQ36348056
Ionic Blockage of Sodium Channels in NerveQ36388606
NMDA receptors in clinical neurology: excitatory times aheadQ36660216
Amantadine: the journey from fighting flu to treating Parkinson disease.Q37999777
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connectionsQ38014513
NMDA receptors in nervous system diseases.Q38098824
NMDA receptors and memory encodingQ38102828
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.Q38131223
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary SupplementQ38666754
Whole-cell patch-clamp analysis of recombinant NMDA receptor pharmacology using brief glutamate applicationsQ38975453
NMDA receptors: linking physiological output to biophysical operation.Q39182931
Classics in Chemical Neuroscience: MemantineQ39454363
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptorsQ39563266
N-methyl-D-aspartic acid receptor structure and functionQ40674725
Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.Q41502069
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.Q41509275
AMPAR interacting protein CPT1C enhances surface expression of GluA1-containing receptors.Q41889628
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virusQ42103503
Key binding interactions for memantine in the NMDA receptor.Q42565522
Neramexane: a moderate-affinity NMDA receptor channel blocker: new prospects and indicationsQ42637057
Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damageQ44395839
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogsQ46292312
Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.Q47255869
Trapping channel block of NMDA-activated responses by amantadine and memantineQ73271990
Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel blockQ77299364
Novel benzopolycyclic amines with NMDA receptor antagonist activityQ87607803
P433issue11
P304page(s)2722-2730
P577publication date2018-06-01
P1433published inACS Chemical NeuroscienceQ2819059
P1476titlePharmacological and Electrophysiological Characterization of Novel NMDA Receptor Antagonists
P478volume9

Reverse relations

Q92132940Dual action of amitriptyline on NMDA receptors: enhancement of Ca-dependent desensitization and trapping channel blockcites workP2860

Search more.